PCI
Procedurepercutaneous angioplasty and stent implantation in coronary artery with significant atherosclerosis and stenosis
Other names: percutaneous coronary intervention
NCT Number: NCT02756000
The study will compare clinical outcomes between complete revascularization during hospitalization for ST elevation myocardial infarction (STEMI) and intervention after 30 days and intervention based on outpatient non-invasive ischemia testing in patients with multivessel coronary artery disease (MVD) presenting with first ever ST elevation myocardial infarction.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Not applicable
Clinical Hospital Center Zemun, Belgrade, Serbia
This study is prospective, randomized, multicentre, open label study in patients with ST elevation myocardial infarction (STEMI) with multivessel coronary artery disease (MVD) defined as >70% stenosis in a non-culprit vessel, initially treated with culprit only primary PCI. The patients will be enrolled in four high volume PCI centers after successful culprit only primary PCI and then randomly assigned to one of three treatment arms:1. complete revascularization of all non-culprit significant lesions in a single session during initial hospitalization; 2. same revascularization in a single session after 30 days; 3.revascularization or it's deferral based on ischemia testing using Dobutamin stress echocardiography. The study will explore differences in occurrence of major adverse cardio-cerebral events (cardiac death, repeated myocardial infarction, cerebrovascular accident and repeated revascularization) and complications of interventions during 12 months follow-up.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
percutaneous angioplasty and stent implantation in coronary artery with significant atherosclerosis and stenosis
Other names: percutaneous coronary intervention
Echocardiographic stress test of provoked myocardial ischemia using dobutamine
Time frame: one year
cardiac death, repeated myocardial infarction, cerebrovascular accident and repeated revascularization
Time frame: one year
Occurence of death caused by cardiac condition
Time frame: one year
Occurrence of repeated myocardial infarction in the study groups
Time frame: one year
Occurrence of vascular complications of PCI, contrast induced nephropathy (CIN) and bleeding events
Time frame: two years
Occurrence of stent thrombosis based on Associated Research Consortium (ARC) criteria
Time frame: one year
Occurrence of hospitalization for heart failure in the study groups
Clinical Hospital Center Zemun
Other
Appropriate Timing of Complete Revascularization for Multivessel Coronary Artery Disease After Culprit Only Primary Percutaneous Coronary Intervention (PCI) for ST Elevation Myocardial Infarction
Acronym: MVD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02425345
Arterial Occlusive Diseases, Arteriosclerosis
View Trial DetailsNCT03161678
Cardiovascular Diseases, Embolism and Thrombosis
Lancaster, Pennsylvania, United States
View Trial DetailsNCT04123197
Cardiovascular Diseases, Heart Diseases
Atlanta, Georgia, United States
View Trial DetailsNCT05820295
Arrhythmias, Cardiac, Atrial Fibrillation
New York, United States
View Trial Details